Goldstream Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-500
Closed -$47.4K 32
2024
Q1
$47.4K Hold
500
0.03% 26
2023
Q4
$44.6K Sell
500
-1,700
-77% -$126K 0.03% 27
2023
Q3
$161K Hold
2,200
0.13% 38
2023
Q2
$183K Hold
2,200
0.13% 34
2023
Q1
$168K Sell
2,200
-12,400
-85% -$1.03M 0.18% 27
2022
Q4
$1.21M Buy
14,600
+5,600
+62% +$453K 1.78% 6
2022
Q3
$714K Sell
9,000
-21,800
-71% -$1.84M 0.6% 7
2022
Q2
$2.29M Buy
+30,800
New +$2.31M 1.99% 4

Other funds holding XBI